Myelodysplastic

Syndrome Myelodysplastic Syndrome (MDS) is a type of blood cancer that occurs when the bone marrow does not produce enough healthy blood cells. MDS can cause serious complications and can even lead to death if left untreated. The exact cause of MDS is unknown, but certain genetic, environmental, and lifestyle factors can increase a person's risk of developing the syndrome. People who have a weakened immune system are more likely to develop MDS. Symptoms of MDS can include fatigue, shortness of breath, bruising, and bleeding. Diagnosis of MDS is done through blood tests, bone marrow tests, and imaging tests. Treatment of MDS can involve medications, stem cell transplants, or biological therapies. MDS is a serious, potentially life-threatening condition, and it is important for individuals to be aware of the risks and symptoms of the syndrome. Early diagnosis and treatment are key for better outcomes.

← Journal of Advances in Leukemia

Related Articles

1 journal(s) found

Advances in Leukemia

ISSN: Coming Soon
Type: Open Access Journal
Editor-in-Chief: Anil Tombak, Mersin University, Medical Faculty.
Journal of Advances in Leukemia is an advanced, peer reviewed journal which brings current information to all health care scientists involved in basic clinical research area. The Journal seeks high-quality submissions and welcome authors to submit articles of type reviews, letters, editorials, case reports, short communications and original researc